| Literature DB >> 34508496 |
Sudeep Regmi1, Arnab Ghosh1, Dilasma Gharti Magar1, Sushma Thapa1, Krishna Prasad Koirala2, Om Prakash Talwar1.
Abstract
INTRODUCTION: Sinonasal and nasopharyngeal regions harbor diverse clinical conditions including many non-neoplastic and neoplastic lesions presenting with nasal obstruction, facial pain and swelling, rhinorrhea, epistaxis, and other oral, ear, and orbital symptoms. Histopathology of excised lesions is the mainstay for the definitive diagnosis and management of neoplastic lesions. The aim of this study is to find out the prevalence of neoplastic lesions among sinonasal and nasopharyngeal masses.Entities:
Mesh:
Year: 2021 PMID: 34508496 PMCID: PMC9107868 DOI: 10.31729/jnma.6859
Source DB: PubMed Journal: JNMA J Nepal Med Assoc ISSN: 0028-2715 Impact factor: 0.556
Distribution of neoplastic lesions according to gender (n = 134
| Type of Lesion | Gender | n (%) | |
|---|---|---|---|
| Female n (%) | Male n (%) | ||
| Benign | 27 (20.1) | 46 (34.3) | 73 (54.4) |
| Intermediate | 1 (0.7) | 0 (0.0) | 1 (0.7) |
| Malignant | 28 (20.8) | 32 (23.8) | 60 (44.7) |
| Total | 56 (41.7) | 78 (58.2) | 134 (100) |
Includes dysplastic lesions.
Distribution of neoplastic lesions according to the age group (n=134).
| Age Group | Type of Lesion | n (%) | ||
|---|---|---|---|---|
| Benign n (%) | Intermediate n (%) | Malignant | ||
| <10 Years | 3 (2.2) | 0 (0.0) | 2 (1.4) | 5 (3.7) |
| 11-20 Years | 11 (8.2) | 0 (0.0) | 1 (0.7) | 12 (8.9) |
| 21-30 Years | 15 (11.1) | 0 (0.0) | 0 (0.0) | 15 (11.1) |
| 31-40 Years | 10 (7.4) | 1 (0.7) | 4 (2.98) | 15 (11.1) |
| 41-50 Years | 10 (7.4) | 0 (0.0) | 7 (5.2) | 17 (12.6) |
| 51-60 Years | 9 (6.7) | 0 (0.0) | 19 (14.1) | 28 (20.8) |
| 61-70 Years | 9 (6.7) | 0 (0.0) | 13 (9.7) | 22 (16.4) |
| >70 Years | 6 (4.4) | 0 (0.0) | 14 (10.4) | 20 (14.9) |
| Total | 73 (54.4) | 1 (0.7) | 60 (44.7) | 134 (100.0) |
Includes dysplastic lesions.
Distribution of lesions according to the site (n=134).
| Lesion | Nasal Cavity (NC) n (%) | Nasopharynx (NAP) n (%) | Paranasal Sinus (PNS) n (%) | NC+NP n (%) | NC+PNS n (%) | NC+NP+PNS n (%) | Total n (%) |
|---|---|---|---|---|---|---|---|
|
| 65 (48.5) | 3 (2.2) | 2 (1.4) | 0 | 3 (2.2) | 0 | 73 (54.4) |
|
| 1 (0.7) | 0 | 0 | 0 | 0 | 0 | 1 (0.7) |
|
| 41 (30.5) | 15 (11.1) | 2 (1.4) | 0 | 1 (0.7) | 1 (0.7) | 60 (44.7) |
|
| 107 (79.8) | 18 (13.4) | 4 (2.9) | 0 | 4 (2.9) | 1 (0.7) | 134 (100) |
Includes dysplastic lesions.
Neoplastic lesions of the study (n = 134).
| Lesion | n (%) | Lesion | n (%) |
|---|---|---|---|
|
| 73 (54.4) | ||
| Inverted Papilloma | 28 (20.8) | Meningioma | 1 (0.7) |
| Capillary Hemangioma | 23 (17.1) | Nevus | 1 (0.7) |
| Angiofibroma | 8 (5.9) | Nasal Glioma | 1 (0.7) |
| Squamous Papilloma | 7 (5.2) | Sebaceous Adenoma | 1 (0.7) |
| Cavernous Hemangioma | 2 (1.4) | Trichoepithelioma | 1 (0.7) |
|
| 1 (0.7) | ||
| Epithelioid Hemangioendothelioma | 1 (0.7) | ||
|
| 60 (44.7) | ||
| Squamous Cell Carcinoma | 12 (8.9) | Olfactory Neuroblastoma | 2 (1.4) |
| Nasopharyngeal Carcinoma | 12 (8.9) | Positive for Malignancy | 2 (1.4) |
| Basal Cell Carcinoma | 6 (4.47) | Rhabdomyosarcoma | 2 (1.4) |
| Sinonasal Undifferentiated Carcinoma | 5 (3.7) | Sinonasal Adenocarcinoma | 2 (1.4) |
| Non-Hodgkin Lymphoma | 5 (3.7) | Malignant Peripheral Nerve Sheath Tumor | 1 (0.7) |
| Adenoid Cystic Carcinoma | 3 (2.2) | Osteosarcoma | 1 (0.7) |
| Malignant Melanoma | 3 (2.2) | Poorly Differentiated Carcinoma | 1 (0.7) |
| Inverted Papilloma with Dysplasia | 2 (1.4) | Nasal Polyp with Dysplasia | 1 (0.7) |